Alerts will be sent to your verified email
Verify Email
KIMIABL
|
Kimia Biosciences
|
Coral Laboratories
|
Krebs Biochem.&Inds
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-352.38 % | 6.99 % | 56.46 % |
|
5yr Avg Net Profit Margin
|
-2.03 % | 12.64 % | -60.0 % |
|
Price to Book
|
0.0 | 0.83 | 0.0 |
|
P/E
|
18.66 | 9.4 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
28.76 Days | 26.14 Days | -861.42 Days |
|
5yr Average Interest Coverage Ratio
|
0.28 | 114.88 | -5.02 |
|
5yr Avg ROCE
|
-0.98 % | 8.79 % | -22.06 % |
|
5yr Avg Operating Profit Margin
|
1.32 % | 11.85 % | -38.55 % |
|
5 yr average Debt to Equity
|
29.7 | 0.03 | -2.12 |
|
5yr CAGR Net Profit
|
n/a | 17.24 % | -7.31 % |
|
5yr Average Return on Assets
|
-2.12 % | 5.83 % | -17.59 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
74.94 % | 71.51 % | 72.74 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Kimia Biosciences
|
Coral Laboratories
|
Krebs Biochem.&Inds
|
|---|